
Introduction
Summary
In 2020, an estimated 604 000 women were diagnosed with cervical cancer worldwide and about 342 000 women died from the disease. The main cause of cervical cancer is persistent infection with high-risk types of human papillomavirus (HPV), an extremely common family of viruses that are transmitted through sexual contact. Vaccines exist that protect against high-risk HPV types, and screening programmes can detect signs of disease at an early stage, allowing for effective treatment and management of the condition. This means that cervical cancer should be one of the most preventable and treatable forms of cancer. In many high-income countries, this is the case. High incidence rates and high mortality rates of cervical cancer occur mainly (~90% for both) in low- and middle-income countries.
News & Events
News & Events
News
Researchers from IARC and partners find that almost 7 in 10 premature cancer deaths in women could have been prevented
Read More
27.09.2023
Press Releases
Press Releases
Press Release
CanScreen5: a global data repository for breast, cervical, and colorectal cancer screening programmes
Go to PDF
27.04.2023
Highlights
Highlights
Featured News
IARC marks Cervical Cancer Awareness Month 2023
Read More
03.01.2023
Videos
Videos
Recording
Dr Partha Basu on the new IARC atlas: a practical online guide for using HPV tests
WATCH VIDEO
03.03.2023
Infographics
Infographics
Infographic
Launch of the EASTER project to validate new technologies for cervical cancer screening and diagnosis
Read More
05.09.2023
Q&As
Q&As
IARC Handbooks of Cancer Prevention Volume 18:
Evaluation of cervical cancer screening methods
What is the IARC Handbooks series?